Operating Income
Revolution Medicines, Inc. Operating Income decreased by 23.1% to -$445.22M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 84.9%, from -$240.76M to -$445.22M. Over 4 years (FY 2021 to FY 2025), Operating Income shows a downward trend with a 58.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
operating_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.54M | -$53.16M | -$52.91M | -$57.95M | -$62.09M | -$76.53M | -$61.71M | -$75.16M | -$108.80M | -$123.25M | -$179.98M | -$140.86M | -$156.64M | -$175.71M | -$216.31M | -$240.76M | -$264.71M | -$315.27M | -$361.63M | -$445.22M |
| QoQ Change | — | -19.4% | +0.5% | -9.5% | -7.1% | -23.3% | +19.4% | -21.8% | -44.8% | -13.3% | -46.0% | +21.7% | -11.2% | -12.2% | -23.1% | -11.3% | -9.9% | -19.1% | -14.7% | -23.1% |
| YoY Change | — | — | — | — | -39.4% | -44.0% | -16.6% | -29.7% | -75.2% | -61.0% | -191.7% | -87.4% | -44.0% | -42.6% | -20.2% | -70.9% | -69.0% | -79.4% | -67.2% | -84.9% |
Operating Income at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s operating income?
- Revolution Medicines, Inc. (RVMD) reported operating income of -$445.22M in Q1 2026.
- How has Revolution Medicines, Inc.'s operating income changed year-over-year?
- Revolution Medicines, Inc.'s operating income decreased by 84.9% year-over-year, from -$240.76M to -$445.22M.
- What is the long-term trend for Revolution Medicines, Inc.'s operating income?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s operating income has grown at a 58.4% compound annual growth rate (CAGR), from -$188.01M to -$1.18B.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.